• STAT Plus: With a detailed rundown, Pfizer seeks to paint a picture of a research turnaround

    16 days ago - By STAT

    Pfizer has been making headlines because of its work developing a Covid-19 vaccine. On Monday and Tuesday, the company is hoping some of that buzz will rub off on its other research projects, which will be presented in a two-part investor day Monday and Tuesday.
    Such meetings are a common way for companies to drum up investor interest. But Mikael Dolsten , Pfizer's chief scientific officer, said in an interview with STAT that never before in his decadelong tenure running the company's labs has such a meeting focused so squarely on the company's research and development efforts, not its...
    Read more ...